5-Nucleotidase (CD73 or Ecto-5-Nucleotidase or EC 3.1.3.5) - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth
The report provides comprehensive information on the 5'-Nucleotidase (CD73 or Ecto-5'-Nucleotidase or EC 3.1.3.5), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in 5'-Nucleotidase (CD73 or Ecto-5'-Nucleotidase or EC 3.1.3.5) targeted therapeutics development and...
View full press release